116 related articles for article (PubMed ID: 23175345)
1. ["Vicious circles" of glioblastoma tumors: vascularization and invasiveness].
Szala S; Jarosz M; Smolarczyk R; Cichoń T
Postepy Hig Med Dosw (Online); 2012 Nov; 66():888-900. PubMed ID: 23175345
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1α in human glioblastoma.
Clara CA; Marie SK; de Almeida JR; Wakamatsu A; Oba-Shinjo SM; Uno M; Neville M; Rosemberg S
Neuropathology; 2014 Aug; 34(4):343-52. PubMed ID: 24612214
[TBL] [Abstract][Full Text] [Related]
3. HIV protease inhibitors decrease VEGF/HIF-1alpha expression and angiogenesis in glioblastoma cells.
Pore N; Gupta AK; Cerniglia GJ; Maity A
Neoplasia; 2006 Nov; 8(11):889-95. PubMed ID: 17132220
[TBL] [Abstract][Full Text] [Related]
4. DNA-PKcs deficiency inhibits glioblastoma cell-derived angiogenesis after ionizing radiation.
Liu Y; Zhang L; Liu Y; Sun C; Zhang H; Miao G; Di CX; Zhou X; Zhou R; Wang Z
J Cell Physiol; 2015 May; 230(5):1094-103. PubMed ID: 25294801
[TBL] [Abstract][Full Text] [Related]
5. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
6. Enhanced cancer therapy with the combination of EGFR and VEGFR-2 targeting in an orthotopic glioblastoma model.
Diao Y; Tian XH; Huang YL; Chen LK; Lin XN; Zhuang ZW
J Chemother; 2010 Dec; 22(6):407-12. PubMed ID: 21303749
[TBL] [Abstract][Full Text] [Related]
7. Computational Trials: Unraveling Motility Phenotypes, Progression Patterns, and Treatment Options for Glioblastoma Multiforme.
Raman F; Scribner E; Saut O; Wenger C; Colin T; Fathallah-Shaykh HM
PLoS One; 2016; 11(1):e0146617. PubMed ID: 26756205
[TBL] [Abstract][Full Text] [Related]
8. [The sodium pump could constitute a new target to combat glioblastomas].
Lefranc F; Mijatovic T; Kiss R
Bull Cancer; 2008 Mar; 95(3):271-81. PubMed ID: 18390407
[TBL] [Abstract][Full Text] [Related]
9. The glioblastoma vasculature as a target for cancer therapy.
Dimberg A
Biochem Soc Trans; 2014 Dec; 42(6):1647-52. PubMed ID: 25399584
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a bispecific biological drug designed to simultaneously target glioblastoma and its neovasculature in the brain.
Oh S; Tsai AK; Ohlfest JR; Panoskaltsis-Mortari A; Vallera DA
J Neurosurg; 2011 Jun; 114(6):1662-71. PubMed ID: 21294620
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of CD31/platelet endothelial cell adhesion molecule 1 (PECAM1) correlates with hypoxia inducible factor-1 alpha (HIF-1α) in human glioblastoma multiforme.
Musumeci G; Castorina A; Magro G; Cardile V; Castorina S; Ribatti D
Exp Cell Res; 2015 Dec; 339(2):407-16. PubMed ID: 26376118
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of evasion to antiangiogenic therapy in glioblastoma.
Rose SD; Aghi MK
Clin Neurosurg; 2010; 57():123-8. PubMed ID: 21280504
[No Abstract] [Full Text] [Related]
13. Migration pathways of human glioblastoma cells xenografted into the immunosuppressed rat brain.
Guillamo JS; Lisovoski F; Christov C; Le Guérinel C; Defer GL; Peschanski M; Lefrançois T
J Neurooncol; 2001 May; 52(3):205-15. PubMed ID: 11519850
[TBL] [Abstract][Full Text] [Related]
14. Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment.
Gao H; Yang Z; Cao S; Xiong Y; Zhang S; Pang Z; Jiang X
Biomaterials; 2014 Feb; 35(7):2374-82. PubMed ID: 24342723
[TBL] [Abstract][Full Text] [Related]
15. An Experimenter's Guide to Glioblastoma Invasion Pathways.
de Gooijer MC; Guillén Navarro M; Bernards R; Wurdinger T; van Tellingen O
Trends Mol Med; 2018 Sep; 24(9):763-780. PubMed ID: 30072121
[TBL] [Abstract][Full Text] [Related]
16. Determination of an optimal dosing schedule for combining Irinophore C™ and temozolomide in an orthotopic model of glioblastoma.
Verreault M; Wehbe M; Strutt D; Masin D; Anantha M; Walker D; Chu F; Backstrom I; Kalra J; Waterhouse D; Yapp DT; Bally MB
J Control Release; 2015 Dec; 220(Pt A):348-357. PubMed ID: 26528901
[TBL] [Abstract][Full Text] [Related]
17. Melatonin antagonizes hypoxia-mediated glioblastoma cell migration and invasion via inhibition of HIF-1α.
Zhang Y; Liu Q; Wang F; Ling EA; Liu S; Wang L; Yang Y; Yao L; Chen X; Wang F; Shi W; Gao M; Hao A
J Pineal Res; 2013 Sep; 55(2):121-30. PubMed ID: 23551342
[TBL] [Abstract][Full Text] [Related]
18. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.
Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K
Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107
[TBL] [Abstract][Full Text] [Related]
19. Correlation between glioblastoma stem-like cells and tumor vascularization.
He H; Niu CS; Li MW
Oncol Rep; 2012 Jan; 27(1):45-50. PubMed ID: 21971709
[TBL] [Abstract][Full Text] [Related]
20. Metabolic modulation of glioblastoma with dichloroacetate.
Michelakis ED; Sutendra G; Dromparis P; Webster L; Haromy A; Niven E; Maguire C; Gammer TL; Mackey JR; Fulton D; Abdulkarim B; McMurtry MS; Petruk KC
Sci Transl Med; 2010 May; 2(31):31ra34. PubMed ID: 20463368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
